Manager, AI Innovation at Bristol-Myers Squibb

Warsaw, Woj. Mazowieckie, Poland

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalIndustries

Requirements

MS, PhD, or equivalent advanced degree of relevance in AI-driven solutions
5+ years of experience working in/with the pharmaceutical industry
Good verbal and written communication skills (both in English and local language)
Expertise in leading digital health programs
Successful track record of leading through influence and working across complex, global organizational matrices

Responsibilities

Forging strong partnerships with commercial leaders across Europe to uncover high-impact opportunities where AI and digital technology can transform outcomes in priority therapeutic areas
Scouting, evaluating, and implementing breakthrough AI-powered solutions by leveraging internal capabilities and external partnerships—improving patient outcomes and enhancing business operations to drive BMS growth and portfolio differentiation
Facilitating collaboration across internal teams and with external innovators—including healthcare providers and technology companies—to co-develop and pilot new solutions, ensuring a steady inflow of fresh ideas and approaches
Crafting compelling business cases that energize investment and mobilize cross-functional support, translating complex AI and digital strategies into clear commercial growth
Orchestrating seamless delivery from concept to launch by aligning diverse teams—Marketing, Sales, Medical, BI&A, Legal, Quality, Regulatory, and Procurement—behind bold commercial ambitions
Maximizing deployment by setting clear, ambitious impact metrics and rigorously tracking performance, ensuring every solution delivers measurable value for patients and drives business momentum
Inspiring a culture of innovation and agility, empowering teams to challenge conventions, embrace new technologies, and fuel sustained growth through both internal and external AI-driven transformation across BMS

Skills

Digital Solutions

Commercial Strategy

Partnerships

Innovation Management

Technology Evaluation

Patient Outcomes

Therapeutic Areas

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free